Wednesday, October 29, 2014 4:05 PM
MILAN—Against the backdrop of a strong third fiscal quarter, which saw increases in the company’s retail and wholesale division, worldwide,
said its board of directors, today, upon the chairman Leonardo Del Vecchio’s recent proposal, entrusted Massimo Vian, on an interim basis, with all executive responsibilities until Adil Mehboob-Khan joins Luxottica as co-CEO.
Wednesday, October 29, 2014 12:23 AM
(NVS: NYSE) delivered solid sales growth with strong margin expansion and major innovation in the third quarter ended Sept. 30, 2014.
Wednesday, October 29, 2014 12:14 AM
IRVINE, Calif.—With net sales of $1,790.7 million for the third quarter ended Sept. 30, 2014, a 17.2 percent increase over net sales for the third quarter of 2013,
(NYSE: AGN) reported its “strongest increase in absolute dollar sales in any quarter in our history,” according to David E.I. Pyott, chairman and CEO, in a statement released by Allergan on Monday, Oct. 27, 2014.
Monday, October 27, 2014 12:23 AM
(Reuters: ESSI.PA) announced Friday that consolidated revenue for the third quarter of 2014, ending Sept. 30, climbed to €1,415 million, an increase of 14.5 percent, excluding the currency effect, over third quarter 2013.
Wednesday, October 22, 2014 12:23 AM
LAVAL, Quebec—Valeant Pharmaceuticals, Inc. (NYSE/TSX: VRX) reported its total revenue for the third fiscal quarter ended Sept. 30, 2014, was $2.1 billion, up 33 percent compared to the third quarter of 2014, with the U.S. and emerging market businesses contributing strong double-digit, same-store organic growth.
Wednesday, October 22, 2014 12:20 AM
New Look Eyewear Inc.
((TSX: BCI)), the Canadian optical retailer, completed its acquisition of certain optical assets and business forming part of Optic Direct Inc, carrying on business under the
Greiche & Scaff
banner in Quebec.
Wednesday, October 15, 2014 12:23 AM
NEW BRUNSWICK, N.J.—Boosted by a strong performance by its pharmaceutical business,
Johnson & Johnson
(NYSE: JNJ) yesterday reported sales of $18.5 billion for the third quarter of 2014, an increase of 5.1 percent versus third quarter 2013.
Friday, October 10, 2014 12:23 AM
MADISON, Wis.—Earlier this week on Wednesday, Oct. 8, 2014, optometric software provider,
received a financial investment from RevOptix, a newly formed private investment group headed by executive chairman Gunnar Bjorklund.
Friday, October 10, 2014 12:17 AM
VANCOUVER, British Columbia—
(Nasdaq:QLTI) (TSX:QLT) said it has been advised by
Auxilium Pharmaceuticals, Inc.
that Auxilium's board of directors has reviewed an offer from
Endo International plc
to acquire all of the issued and outstanding shares of Auxilium.
Wednesday, October 08, 2014 12:23 AM
((NYSE: AGN), which is continuing its efforts to fend off an unsolicited, $54 billion takeover bid by
Valeant Pharmaceuticals International
(NYSE: VRX), the parent company of Bausch + Lomb Inc., asked a judge to block Bill Ackman’s Pershing Square from voting at a shareholder meeting scheduled for December.
Wednesday, October 08, 2014 12:20 AM
ZeaVision Holdings, Inc
., supplier of nutritional supplements for eye health, has received an equity investment from DSM Venturing, the corporate venture arm of Royal DSM, the global life sciences and material sciences company.
Friday, October 03, 2014 12:23 AM
LARGO, Fla.—Specialty contact lens supplier,
Unilens Vision Inc.’s
(OTCQX: UVIC) net income increased 115.3 percent to $277,636 in the fourth quarter ended June 30, 2014, when compared with net income of $128,960 during the comparable fourth quarter period of 2013, according to operating results just released by the company.
Friday, September 26, 2014 12:23 AM
Unilens Vision Inc.’s
(OTCQX: UVIC) common stock has been approved to trade on the OTCQX exchange, described as “the best marketplace within
OTC Markets Group
[OTCQX: OTCM] for established U.S. and global companies,” according to a statement released yesterday by OTC Markets Group, the operator of the OTCQX, OTCQB and OTC Pink financial marketplaces.
Friday, September 19, 2014 12:26 AM
(NYSE: AGN) announced that it has reached an agreement with Pershing Square Capital Management, L.P. and
(NYSE: VRX) under which Allergan will hold the Special Meeting of Stockholders on the originally scheduled date of Dec.18, 2014, without restriction, and Pershing Square and Valeant will dismiss their pending litigation before the Delaware Court of Chancery.
Monday, September 08, 2014 12:26 AM
(NYSE: AGN) provided an update regarding the validity of the written requests from Allergan stockholders that were delivered by Pershing Square Capital Management, L.P. to request a Special Meeting of Stockholders.